NCT01527084

Brief Summary

  1. 1.To determine the appropriate timing of surgical intervention after Percutaneous Catheter Drainage (PCD) in infected pancreatic necrosis (IPN).
  2. 2.To see the change in morbidity and mortality after changing the interval of surgery after PCD

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2011

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 21, 2012

Completed
16 days until next milestone

First Posted

Study publicly available on registry

February 6, 2012

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

November 11, 2014

Status Verified

November 1, 2014

Enrollment Period

1.4 years

First QC Date

January 21, 2012

Last Update Submit

November 8, 2014

Conditions

Outcome Measures

Primary Outcomes (4)

  • Mortality

    participants will be followed for the duration of hospital stay, an expected average duration of 5 weeks

  • Reversal of existing organ failure

    participants will be followed for the duration of hospital stay, an expected average duration of 5 weeks

  • New onset multiorgan failure or sepsis and systemic complications

    participants will be followed for the duration of hospital stay, an expected average duration of 5 weeks

  • Locoregional complications

    Pseudocyst, Pancreatic fistula, Enteric fistula, Perforation of a hollow viscus, and bleeding requiring intervention

    participants will be followed for the duration of hospital stay, an expected average duration of 5 weeks

Secondary Outcomes (3)

  • Proportion of patients in which surgery would be avoided in Group B

    participants will be followed for the duration of hospital stay, an expected average duration of 5 weeks

  • Pancreatic insufficiency (New onset Diabetes and steatorrhea)

    participants will be followed for the duration of hospital discharge to end of our study period, an expected average duration of 1 year

  • Total number of PCD catheters and catheter related interventions required, and catheter and drain related complications

    participants will be followed for the duration of hospital stay, an expected average duration of 5 weeks

Study Arms (2)

Group A

OTHER

undergo surgery between days 10 - 15 after PCD

Procedure: surgical intervention after percutaneous catheter drainage

Group B

OTHER

continued with PCD beyond 15 days and indications for surgery in them will be, 1. Persistent sepsis or symptoms 2. Worsening of clinical condition 3. Failure to thrive 4. Complications of SAP or PCD

Procedure: surgical intervention after percutaneous catheter drainage

Interventions

Patients who are not improving by day 10 after PCD insertion will be included in the present study and are randomized to group A (early surgery i.e. between 10-15days after PCD insertion ) or group B (Extended treatment with PCD with saline irrigation for more than 15days after PCD insertion)

Group AGroup B

Eligibility Criteria

Age14 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All patients with diagnosis of IPN (UK GUIDELINES) managed with percutaneous catheter drainage (PCD) for 10 to 15 days and not showing significant improvement on PCD will be included

You may not qualify if:

  • Patient showing significant improvement on PCD within 10 days of its insertion.(Significant improvement on PCD is defined as resolution of fever, acceptance of enteral nutrition, decrease in total leukocyte count, reversal of organ system failure)
  • Sterile pancreatic necrosis
  • An acute intra abdominal event ( perforation of hollow viscus, bleeding, or the abdominal compartment syndrome) during or within 10 days after PCD insertion
  • Previous drainage or surgical necrosectomy for infected pancreatic necrosis (ERCP with or without papillotomy is allowed.)
  • Previous exploratory laparotomy for acute abdomen and diagnosis of pancreatitis during laparotomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

PGIMER

Chandigarh, Chandigarh, 160012, India

Location

Postgraduate Institute of Medical Education and Research

Chandigarh, 160012, India

Location

MeSH Terms

Conditions

Pancreatitis

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System Diseases

Study Officials

  • Rajesh Gupta, MBBS,MS, MCh

    Post Graduate Institute of Medical Education and Research, Chandigarh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 21, 2012

First Posted

February 6, 2012

Study Start

July 1, 2011

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

November 11, 2014

Record last verified: 2014-11

Locations